Small Molecule Videos

  1. Integrated CDMO Services 10/21/2024

    We offer a comprehensive suite of services, including formulation development, GMP manufacturing, quality control, and extensive analytical capabilities.

  2. Accelerating Nasal Dosage Form Development From Early-Phase To Clinical Trial Manufacture 10/21/2024

    Led by Dr. Richard Johnson, Chief Scientific Officer, this 40-minute session covers the five key stages of the UpperNose development platform, highlighting the significance of target product selection and its influence on formulation and clinical outcomes.

  3. Use Of Spray Drying In Pharmaceutical Product Development 10/21/2024

    Through this detailed exploration, participants will gain valuable knowledge on how to leverage spray drying to optimize drug development and delivery.

  4. Achieving Manufacturing Efficiency In OSD Manufacturing 10/16/2024

    Gain expert insight into the importance of instrumented tablet presses in assessing formulation properties, the role of tablet cup configurations, and scalability parameters for successful product transfer.

  5. Expanding The OSD Toolbox 10/3/2024

    This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.

  6. Understanding Nitrosamines: Key Regulations And Best Practices 10/2/2024

    Gain expert insights into nitrosamine regulations and discover practical strategies for ensuring compliance and safeguarding product safety.

  7. Understanding FDA Calibration Requirements And Best Practices For Reducing Risks 10/2/2024

    Become equipped with the tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.

  8. Enabled Form Selection For Oral Drug Products 9/30/2024

    Review the role of solid form screening and PBPK modeling to enable accelerated timelines desirable in early-phase drug development. Explore formulation maps for ASDs and key criteria for salt screening.

  9. Advances In Oral GLP-1 Analogs For Obesity 9/12/2024

    Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.

  10. Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions 9/10/2024

    Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.